Science Explorer Back to mapMap
Discussion
Company · Montreal · Canada

Innovaderm (Canada)

Research works
92
▲ 75% vs 2018-21
Citations
3.2k
34.8 per fractional work
Top-10% rate
21.6%
all institutions 10.0%
Open access
37%
world 40%
International
66%
world 18%

Not ranked overall: Innovaderm (Canada) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Innovaderm (Canada) work in?

In 2022-now, 65% of research at Innovaderm (Canada) is in Health Sciences, 23% in Life Sciences. Its largest fields are Medicine (64%), Immunology and Microbiology (19%), Engineering (8%). It does 2.3× the world's share of Health Sciences.

Health Sciences: 22 fractional works · 65.0% of its workMedicine: 22 fractional works · 64.1% of its workDermatology: 10 fractional works · 30.3% of its workImmunology and Allergy: 2 fractional works · 7.1% of its workPhysiology: 2 fractional works · 6.5% of its workRheumatology: 2 fractional works · 5.0% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 2.5% of its workPathology and Forensic Medicine: 1 fractional works · 2.0% of its workOncology: 1 fractional works · 1.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.2% of its workComplementary and alternative medicine: 0 fractional works · 1.1% of its workHealth Informatics: 0 fractional works · 0.7% of its workPharmacology: 0 fractional works · 0.7% of its workEpidemiology: 0 fractional works · 0.5% of its workFamily Practice: 0 fractional works · 0.5% of its workGastroenterology: 0 fractional works · 0.5% of its workUrology: 0 fractional works · 0.5% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.4% of its workRehabilitation: 0 fractional works · 0.4% of its workEmergency Medicine: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workSurgery: 0 fractional works · 0.3% of its workHematology: 0 fractional works · 0.3% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.3% of its workInfectious Diseases: 0 fractional works · 0.2% of its workPsychiatry and Mental health: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.6% of its workHealth Professions: 0 fractional works · 0.6% of its workSpeech and Hearing: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.3% of its workPeriodontics: 0 fractional works · 0.3% of its workLife Sciences: 8 fractional works · 23.2% of its workImmunology and Microbiology: 6 fractional works · 18.7% of its workImmunology: 6 fractional works · 18.6% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 1.8% of its workBiotechnology: 0 fractional works · 0.9% of its workMolecular Biology: 0 fractional works · 0.4% of its workCell Biology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 1.3% of its workPlant Science: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.0% of its workToxicology: 0 fractional works · 0.4% of its workPharmaceutical Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.4% of its workBehavioral Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysical Sciences: 4 fractional works · 10.4% of its workEngineering: 3 fractional works · 8.3% of its workElectrical and Electronic Engineering: 2 fractional works · 4.9% of its workControl and Systems Engineering: 1 fractional works · 3.2% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 1.3% of its workStatistics and Probability: 0 fractional works · 1.0% of its workModeling and Simulation: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 0.5% of its workArtificial Intelligence: 0 fractional works · 0.5% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workAstronomy and Astrophysics: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 1.4% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.1% of its workEconomics and Econometrics: 0 fractional works · 1.1% of its workSocial Sciences: 0 fractional works · 0.3% of its workSafety Research: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workALL ITS WORKInnovaderm(Canada)34fractional works, 2022-now
Life Sciences23%Physical Sciences10%Health Sciences65%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine2264.1%
    2. Health Professions00.6%
    3. Dentistry00.3%
    1. Immunology and Microbiology618.7%
    2. Biochemistry, Genetics and Molecular Biology11.8%
    3. Agricultural and Biological Sciences01.3%
    4. Pharmacology, Toxicology and Pharmaceutics01.0%
    5. Neuroscience00.4%
    1. Engineering38.3%
    2. Mathematics01.3%
    3. Computer Science00.5%
    4. Physics and Astronomy00.2%
    1. Economics, Econometrics and Finance01.1%
    2. Social Sciences00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Innovaderm (Canada) specialise in?

Where its research is concentrated relative to its size: Medicine takes 3.3× the share of its output that it takes of world research.

  1. MedicineField · 21.8 works3.3×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.26× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.33× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 18.57× its world share, 6 worksImmunology and Micro…Neuroscience: 0.27× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.83× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.06× its world share, 0 worksComputer ScienceEngineering: 0.56× its world share, 3 worksEngineeringMathematics: 1.11× its world share, 0 worksMathematicsPhysics and Astronomy: 0.11× its world share, 0 worksPhysics and AstronomyDentistry: 0.65× its world share, 0 worksDentistryHealth Professions: 0.24× its world share, 0 worksHealth ProfessionsMedicine: 3.33× its world share, 22 worksMedicineEconomics, Econometrics and Finance: 0.52× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 18.6×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Immunology and Microbiology18.57×6 works
  2. Medicine3.33×22 works
  3. Pharmacology, Toxicology and Pharmaceutics2.83×0 works
  4. Mathematics1.11×0 works
  5. Dentistry0.65×0 works
  6. Engineering0.56×3 works
  7. Economics, Econometrics and Finance0.52×0 works
  8. Biochemistry, Genetics and Molecular Biology0.33×1 works
  9. Neuroscience0.27×0 works
  10. Agricultural and Biological Sciences0.26×0 works
  11. Health Professions0.24×0 works
  12. Physics and Astronomy0.11×0 works
  13. Computer Science0.06×0 works
  14. Social Sciences0.02×0 works

Who are the top researchers at Innovaderm (Canada)?

Ranked on the quality score, Robert Bissonnette, Catherine Maari and Étienne Saint‐Cyr Proulx lead among researchers whose main affiliation is Innovaderm (Canada).

  1. 1 Robert Bissonnette Canada · #83,810 worldwide 18k citations · 483 works
  2. 2 Catherine Maari Canada · #328,063 worldwide 3.8k citations · 102 works
  3. 3 Étienne Saint‐Cyr Proulx Canada · #603,434 worldwide 675 citations · 27 works
  4. 4 Chantal Bolduc Canada · #1,038,943 worldwide 2.3k citations · 52 works
  5. 5 Simon Nigen Canada · #2,705,146 worldwide 1k citations · 34 works
All ranked researchers at Innovaderm (Canada)

What are the most cited papers from Innovaderm (Canada)?

The most cited paper from Innovaderm (Canada) is "The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis" (C. Roubille, Vincent Richer, Tara Starnino et al., 2015), with 908 citations. Next come "Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis" (701) and "Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus" (662).

Most cited papers
#PaperReleasedCitations
1 The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis C. Roubille, Vincent Richer, Tara Starnino et al. · Annals of the Rheumatic Diseases ReviewOpen access 6 Jan 2015 908
2 Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis Emma Guttman‐Yassky, Robert Bissonnette, Benjamin Ungar et al. · Journal of Allergy and Clinical Immunology Open access 5 Sep 2018 701
3 Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus Lasse Roger Braathen, Rolf‐Markus Szeimies, Nicole Basset‐Séguin et al. · Journal of the American Academy of Dermatology 25 Dec 2006 662
4 Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial Eric Lawrence Simpson, Rodney Daniel Sinclair, Seth B. Forman et al. · The Lancet Open access Jul 2020 516
5 A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis Kim Alexander Papp, Kristian Reich, Carle F. Paul et al. · British Journal of Dermatology Open access 25 Feb 2016 470
All 61 most cited papers, with filters and sorting

Which keywords describe research at Innovaderm (Canada)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Filaggrin, Skin Microbiome, Epidemiology, Regulatory T Cells, Immune System, TGF-ß, IL-17 and TH17 Cells.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 28 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 28 words, with their numbers
  1. Filaggrin8▲ 489×1 topic
  2. Skin Microbiome8▲ 489×1 topic
  3. Epidemiology7▲ 5.0×16 topics
  4. Regulatory T Cells5▲ 131×2 topics
  5. Immune System4▲ 56×2 topics
  6. TGF-ß4▲ 82×2 topics
  7. IL-174▲ 367×1 topic
  8. TH17 Cells4▲ 367×1 topic
  9. Asthma3▲ 102×2 topics
  10. Inflammation3▲ 4.7×14 topics
  11. Quality of Life3▲ 6.5×6 topics
  12. Diagnosis2▲ 7.9×5 topics
  13. Treatment2▲ 5.3×5 topics
  14. Genetics2▲ 8.6×3 topics
  15. Management2▲ 7.5×3 topics
  16. Allergic Diseases2▲ 95×1 topic
  17. Eosinophils2▲ 95×1 topic
  18. Immunology2▲ 52×2 topics
  19. Autoantibodies2▲ 20×4 topics
  20. Climate Change2▲ 1.70×2 topics
  21. Allergen-specific Immunotherapy2▲ 143×1 topic
  22. Autoimmune2▲ 95×2 topics
  23. Pollen Allergy2▲ 143×1 topic
  24. Contact Allergy1▲ 181×1 topic
  25. Skin Sensitization1▲ 181×1 topic
  26. Chronic Spontaneous Urticaria1▲ 147×1 topic
  27. Prevalence1▲ 7.2×2 topics
  28. Urticaria1▲ 147×1 topic

Which research topics does Innovaderm (Canada) publish most on?

By volume in 2022-now: Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Asthma and respiratory diseases and Allergic Rhinitis and Sensitization.

  1. 1 Dermatology and Skin Diseases Dermatology 8 works
  2. 2 Psoriasis: Treatment and Pathogenesis Immunology 4 works
  3. 3 Asthma and respiratory diseases Physiology 2 works
  4. 4 Allergic Rhinitis and Sensitization Immunology and Allergy 2 works
  5. 5 Contact Dermatitis and Allergies Dermatology 1 works
  6. 6 Urticaria and Related Conditions Rheumatology 1 works
  7. 7 Food Allergy and Anaphylaxis Research Immunology and Allergy 1 works
  8. 8 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works
  9. 9 IL-33, ST2, and ILC Pathways Immunology 1 works
  10. 10 Spondyloarthritis Studies and Treatments Rheumatology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.1%not open62.9%

World: 40% of research is openly available.

with international co-authors65.9%domestic only34.1%

World: 18% is written across borders.

How has Innovaderm (Canada)'s research output changed?

Output in 2022-2025 was 75% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Innovaderm (Canada) as a percentage of every work published that year, 0.00020% in 2024.

still counting0.00010%0.00020%0.00030%Innovaderm (Canada)0.000100% in 202520102020

Fractional works of Innovaderm (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Montreal

All research institutions in Montreal

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Innovaderm (Canada). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.